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The presenting pattern and natural progression of biochemical markers of biliary tract obstruction in patients with gallstone
pancreatitis have not been elucidated. We analyzed serialvalues of bilirubin levels following admission todischarge in 143 patients.
Ninety-four of patients demonstrated a Decrescendo (falling) pattern of bilirubin levels from admission until normalization
at 21 hours (median). Forty-nine patients demonstrated a Crescendo-Decrescendo (initially rising) pattern with peak levels of
bilirubin occurring at 39 hours after admission followed by a subsequent normalization after a median of 119 hours. Patients in
the Decrescendo group were signiﬁcantly younger (33 versus 41 years, P = .02) and more patients had experienced symptoms for
greater than 48 hours (65% versus 47%, P = .05). Ten percent of patients in the Decrescendo group and 29% of patients in the
Crescendo-Decrescendo group underwent ERCP (P = .02). Normalization of biochemical markers after ERCP was signiﬁcantly
delayed in both groups compared to no ERCP. Older patients present earlier, with higher bilirubin levels and normalize slower
than younger patients, perhaps due to ﬁbrosis of the ampulla and decreased compliance of the common bile duct. Patients who
disobstruct spontaneously (90%) normalize quicker than patients undergoing ERCP.
Copyright © 2009 Mikael Petrosyan et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Background
In Western societies gallstones are a major cause of acute
pancreatitis. The passage of gallstones through the biliary
tract and obstruction of the ampulla have both been
associated with the development of acute pancreatitis [1–4].
Numerous studies have shown a high prevalence of common
bile duct (CBD) stones or ampullary inﬂammation with
obstruction of the biliary tree in patients operated on early
after admission [1, 5–8]. By contrast, patients operated on
laterinthecourseoftheillnessexhibitfewcommonbileduct
stones or ﬁndings of ampullary obstruction. In conjunction
with the recovery of gallstones in the feces [3, 4]o fp a t i e n t s
with gallstone pancreatitis it is felt that in most patients the
CBD stones pass spontaneously and that the obstruction is
usually temporary.
We hypothesize that in gallstone pancreatitis ﬁndings
of an early ampullary obstruction followed by spontaneous
disobstruction as documented in the literature [1–8] should
therefore be reﬂected in the patients’ serum, with a rise and
fall of bilirubin. The aim of the study was to analyze the
natural progression of this biochemical marker of biliary
tract obstruction in patients with gallstone pancreatitis.
The purpose is to use these observations to determine
the timing of spontaneous biochemical resolution and to
allow for informed management decisions, such as need
for ERCP, preoperative use of MRCP, and proper timing of
cholecystectomy.
2. Patients andMethods
From November 2006 to November 2007, 207 consecutive
patients with a clinical history consistent with pancreatitis
were admitted to the Emergency Surgical Services (Non-
Trauma) of the Los Angeles County Hospital + University of2 Gastroenterology Research and Practice
Southern California Medical Center. Patients were included
in this study if they had abdominal pain typical of acute
pancreatitis, radiological evidence of gallstones in the biliary
system, and serum amylase and lipase levels greater than 3
times normal value (amylase >390U/l and Lipase >180U/l)
together with elevated levels of serum bilirubin and/or
alkaline phosphatase. Those patients with a history of
alcohol abuse, hypercalcemia, hypertriglyceridemia, trauma,
or reported use of a medication known to cause pancreatitis
were excluded from the study. A total of sixty-four patients
did not meet the inclusion criteria. The study population
therefore consisted of 143 consecutive patients with gallstone
pancreatitis. There were 27 male patients (19%) and 116
females (81%) with a median age of 35 years (19–94). The
median length of hospital stay was 6 days (2–72).
Once the diagnosis of gallstone pancreatitis had been
established serial laboratory tests of liver function were per-
formed every 6 hours until resolution of the patient’s acute
illness, hepatic derangement, or discharge from hospital.
Since emergent ERCP is not readily available at our facility,
this policy allowed us to closely monitor patients and select
patients who truly needed emergent ERCP. Based on our
clinical laboratory’s normal range of values, abnormal values
were determined as follows: total bilirubin >1mg/dL, direct
bilirubin >0.3mg/dL, and alkaline phosphatase 140U/l. This
was an observational study, and the primary end point
was to determine the natural history of bilirubin levels in
patients with gallstone pancreatitis. Serial bilirubin levels
were analyzed as a function of time in hours and the
following secondary endpoints determined the following.
(i) TAdmission = the time period corresponding to the ﬁrst
laboratory test upon presentation to hospital.
(ii) TPeak = the time period with the highest values of
serum bilirubin.
(iii) Time to Peak = TPeak − TAdmission.
(iv) TNormal = the time period corresponding to when
serum of bilirubin was consistently within normal
values.
(v) TERCP = the time period corresponding to the
performance of the endoscopic retrograde cholan-
giopancreatography (ERCP).
(vi) Time to Normalization = TNormal − TPeak.F o r
patients undergoing ERCP, Time to Normalization
was calculated as TNormal − TERCP.
We found a similarity between serum bilirubin and
alkalinephosphatasewhenevertherewasanincreasingtrend.
Therewasapoorconcordancebetweenbilirubinandalkaline
phosphatase with regard to Time to Normalization. This we
believe is due to the long half life of alkaline phosphatase
of 3 days [9]. Furthermore alkaline phosphatase is not
excreted in the bile. Previous studies have also shown a good
concordance with biliary disobstruction and falling levels of
bilirubin [10]. We therefore chose only bilirubin levels in
calculating Time to Normalization.
Patients were admitted and treated with a standard
protocol: ﬂuid resuscitation with Lactated Ringer’s Solution,
nothing per mouth, serial laboratory testing every six hours,
andclinicalassessmentevery6hours.Theseverityofpancre-
atitiswasassessedatadmissionaccordingtoRanson’scriteria
[11].Thr eepatientsw er ec lassiﬁedassev er epancr eatitiswith
3 or more Ranson’s criteria on admission and prophylactic
antibioticswerestarted.Therewasnomortalityinthisseries.
Right upper quadrant ultrasonography was performed
on admission. Evidence of ongoing biliary obstruction was
assessed biochemically in conjunction with ultrasonography.
Common bile duct (CBD) dilation was determined using the
dimensions established by Bachar et al. [12] for the normal
upper limit of CBD in patients according to age group.
Dilatation was considered present if the CBD diameter of the
patients was greater than the mean ± 2 standard deviations
of normal subjects. The CBD could not be adequately
delineated in 2 patients.
Patients exhibiting signs and symptoms consistent with
cholangitis and those patients with persistent and/or wors-
ening pain were evaluated for ERCP. Cholecystectomy was
performed once the acute illness had resolved and bilirubin
levels had normalized.
3.StatisticalAnalysis
All data is expressed as medians ± interquartile range unless
otherwise stated. Paired data was analyzed using Wilcoxon
sign rank test, and unmatched data using the Wilcoxon rank
sum test. The two-sample t test was used for continuous
variables. Categorical data was analyzed using the Fisher
exact test. All tests were done by using a 2-sided test with
signiﬁcance at P<. 05.
4. Results
Serial biochemical analysis of serum bilirubin and alka-
line phosphatase revealed two distinct patient groups: a
“Decrescendo” group demonstrated an immediate and sus-
tained decrease in bilirubin levels following admission to
hospital and a “Crescendo-Decrescendo” group demon-
strated an initial rise in serum bilirubin levels to a peak
value followed by a subsequent decrease. A total of 94
(66%) patients showed theDecrescendo trend,and 49 (34%)
patients the Crescendo-Decrescendo trend (Table 1). There
were no gender diﬀerences, but patients in the Decrescendo
groupweresigniﬁcantlyyounger.Thedurationofabdominal
pain was similar between the two groups (P = .83).
Interestingly, signiﬁcantly (P = .05) fewer patients presented
with complaints of abdominal pain prior to admission
in the Decrescendo group compared to the Crescendo-
Decrescendo group.
4.1. Bilirubin Levels on Presentation. The median bilirubin
level in the Decrescendo group on presentation (1.7 ±
1.9mg/dL) was similar (P = .91) to the median bilirubin
in the Crescendo-Decrescendo group (1.2 ± 2.2mg/dL)
(Figure 1). The peak bilirubin level occurred after a median
of 39 ± 74 hours in the Crescendo-Decrescendo group. The
peak value (3.0 ± 4.9mg/dL) was signiﬁcantly higher thanGastroenterology Research and Practice 3
Table 1: Patient characteristics in the Decrescendo and Crescendo-Decrescendo groups.
Decrescendo Crescendo-Decrescendo P
n = 94 n = 49
Age (years) 33 (26–52) 41 (31–54) .02
Female gender n = 78 (83%) n = 39 (80%) .67
Pain <48 hours prior to Admission 47% 65% .05
Length of stay (days) 6 (4–7.5) 6 (5–12.5) .01
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Figure 1: Trends of bilirubin levels during hospital stay. Data
is presented as medians (solid circle) and interquartile range
(grey box). Bilirubin levels on admission (Day 0) are shown for
both the Decrescendo and Crescendo-Decrescendo groups. Time
to peak bilirubin values are shown for Crescendo-Decrescendo
Group. Median time to normalization of bilirubin levels depicted
for both groups. There was no signiﬁcant diﬀerence in bilirubin
level on admission between those patients in the Decrescendo
group compared to those in the Crescendo-Decrescendo group
(P = .91).ThepeakbilirubinlevelsintheCrescendo-Decrescendo
group of patients were signiﬁcantly higher than the levels on
admission(P = .003).Dashed(--)lineshowsnormalbilirubinlevel
(1mg/dL).
the initial value at presentation (P = .003). Stratiﬁcation
of bilirubin levels on admission into those patients with
obvious (>5mg/dL), possible (2.4–5mg/dL), and unlikely
(<2.4mg/dL) ampullary obstruction based on the level of
bilirubin showed no diﬀerence between the Decrescendo
and Crescendo-Decrescendo groups (Figure 2). There was
no diﬀerence in age or sex between the 3 categories.
The prevalence of obvious obstructive jaundice deﬁned as
bilirubin >5mg/dL was similar in both groups (P = .243).
4.2. Common Bile Duct Obstruction. Thirty eight percent
(55 of 143) of patients presented with a dilated common
bile duct. Thirty-six patients (39%) in Decrescendo group
had common bile duct dilatation, which was comparable to
the 19 patients (41%) in the Crescendo-Decrescendo group
(P = .76). Thirteen patients (9%) had an obvious common
bile duct stone seen on ultrasound, eight patients (6%) were
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Figure 2: Stratiﬁcation of admission bilirubin levels based on
likelihood of ampullary obstruction. Bilirubin levels <2.4mg/dL
(unlikely), bilirubin levels 2.4–5mg/dL (possible), bilirubin levels
>5mg/dL (likely). Depicted as percentage contribution of each
category in each group. No diﬀerences were noted between patients
in the Decrescendo group compared to the Crescendo-Decrescendo
group (P = .25).
in the Decrescendo group, and 5 patients (2%) were in the
Crescendo-Decrescendo group. There was no diﬀerence in
the total duration of pain between those patients with biliary
dilation and those without (P = .18).
ERCP was performed on 23 patients from the total
population (16%). Criteria for ERCP were based on sus-
tained rise in bilirubin levels with or without elevated
white count. Signiﬁcantly (P = .002) more patients in the
Crescendo-Decrescendo group (29%, 14 of 49) underwent
ERCP as compared to the Decrescendo group (10%, 9
of 94) (Table 2). The ERCP was therapeutic in 52%. No
common bile duct stones were seen on ERCP in 9 (39%)
patients, stone extraction was unsuccessful in 2 (9%), and
sphincterotomyand/orstoneextractionwasperformedin12
of 23 patients (52%). There was no diﬀerence (P = .265)
in the rate of therapeutic ERCP in the Decrescendo group
(66%,6of9)comparedtotheCrescendo-Decrescendogroup
(43%, 6 of 14). Three patients underwent ERCP within 48
hours of the onset of their pain. The prevalence of CBD
obstruction was signiﬁcantly higher (P = .003) in the
Crescendo-Decrescendo group (31%, 15 of 49) compared to
the Decrescendo group (12%, 11 of 94).
4.3. Bilirubin Normalization. Median time to normalization
in the Decrescendo group (21 ± 81 hours) was signiﬁcantly
shorter (P = .001) than the Crescendo group (119 ± 162
hours). If patients who underwent ERCP were excluded,4 Gastroenterology Research and Practice
Table 2: Characteristics in those patients who underwent ERCP versus no ERCP.
ERCP (n = 23) No ERCP (n = 120) P
Age (years) 41 (30–54) 34 (27–54) .17
Duration of symptoms (hours) 48 (48–168) 48 (24–96) .56
Female gender 16 (70%) 100 (83%) .122
Decrescendo: Crescendo-Decrescendo group ratio 9:14 85:35 .002
CBD dilatation on ultrasound 15/23 (65%) 40/118 (34%) .003
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Figure 3: Kaplan Meier plot of Time to Normalization
(<1.0mg/dL) of bilirubin in the Decrescendo group. In patients
not undergoing ERCP, time 0 was the time of admission which
corresponded to the highest bilirubin level for that patient. In
patients undergoing ERCP, time 0 was the day of the ERCP and
time to normalization was calculated from the time of ERCP. Time
to normalization in patients undergoing ERCP was signiﬁcantly
delayed (P = .02).
time to normalization was still signiﬁcantly shorter in the
Decrescendo group (P = .001). The time to normalization
of total bilirubin in patients after an ERCP was signiﬁcantly
longer in both groups (Figures 3 and 4).
4.4. Pancreatic Enzyme Levels. The majority of patients
demonstrated consistent decreases in pancreatic enzymes
from the time of admission. Only six (6%) patients in the
Decrescendo group and 4 (8%) patients in the Crescendo-
Decrescendo group had amylase and lipase levels that
continued to rise after admission (P = .655).
5. Discussion
In our study we described the biochemical patterns we
observed after an attack of gallstone pancreatitis, largely
using bilirubin levels as a marker. Since the use of prophylac-
tic antibiotics for severe acute pancreatitis is still a matter of
discussion [13], Ranson’s criteria were only used to establish
the severity and to distinguish which patients will receive the
antibiotics.
0 5 10 15 20 25
Time from admission (days)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
P = .03
Bilirubin normalization-Crescendo-Decrescendo group
No ERCP
ERCP
Figure 4: Kaplan Meier Plot of Time to Normalization
(<1.0mg/dL) of bilirubin in the Crescendo-Decrescendo group. In
patients not undergoing ERCP, time 0 was the time of admission,
which corresponded to the highest bilirubin level for that patient.
In patients undergoing ERCP, time 0 was the day of the ERCP and
time to normalization was calculated from the time of ERCP. Time
to normalization in patients undergoing ERCP was signiﬁcantly
delayed (P = .03).
It is well documented that patients with ampullary
obstruction experience severe pain [14], and this presumably
would be the motivating factor that brings patients to the
hospital. In our study, patients with gallstone pancreatitis
present at two distinct stages of the disease. The majority
of patients comprise the Decrescendo group where their
symptoms and their biochemical markers were on the
downtrend toward recovery. These patients presented late in
their disease after likely passage of the stone as evidenced
by falling bilirubin levels. These patients tended to be
signiﬁcantly younger, and a larger proportion presented to
the hospital after enduring pain for greater than 48 hours.
A smaller number of patients presented in the Crescendo-
Decrescendo group. These patients had escalation of their
symptoms and initially increasing bilirubin levels, indicative
of persistent biliary obstruction. These patients tended to be
older and more presented with pain for less than 48 hours.
Given the predominant indigent population that our county
facility service serves it is not unexpected that the majority
of our patients are young and seek medical care later in their
disease process. It is possible that all patients with gallstoneGastroenterology Research and Practice 5
pancreatitis have a similar bilirubin trend after an attack of
pancreatitis and that our study only categorizes patient into
two groups because they were studied at or presented at
two diﬀerent time periods in the course of their disease. To
conﬁrm this patients would have to be studied immediately
from the onset of their symptoms, which would not be
practical or possible.
Studies have shown that passage of gallstones through
the biliary tree is associated with pancreatitis [3, 4]. The
passage is conﬁrmed by ﬁnding of gallstones in the feces
[3, 4]. Numerous studies have shown that early in the
pathogenesis of gallstone pancreatitis there is obstruction of
the ampulla of Vater. Acosta et al. [1, 2]a n dA r m s t r o n ge t
al. [5] demonstrated the obstruction to be mechanical with
a high incidence of ampullary stones seen in their patients.
Others have showed that the obstruction might also be
nonmechanical and due to severe inﬂammation and edema
of the ampulla [6, 15, 16]. Irrespective of the cause of the
obstruction, our study conﬁrmed these ﬁnding and showed
that there is biochemical evidence of obstruction as depicted
in the elevated serum bilirubin.
Studies have shown that the mechanical obstruction of
the biliary tract with a gallstone is usually transient and that
most patients spontaneously clear their common bile duct of
gallstones[1,5].Similarlylookingatbiochemicalevidenceof
obstruction we showed that 2/3 of patients have a resolving
obstructionatadmission(Decrescendogroup).Furthermore
inthisstudywedocumentedthetemporalrelationshipofthe
stonepassageusingbiochemicalmarkerofelevatedbilirubin.
Only 1/3 of patients have evidence of persistent or ongoing
obstruction of the biliary tract that is usually short lived with
spontaneous biochemical evidence of disobstruction occur-
ring within 2 days. Spontaneous resolution as conﬁrmed
biochemically by bilirubin normalization occurred in 90%
of patients as only 10% required therapeutic intervention to
remove the oﬀending stone. This is consistent with historical
papersstudyinggallstonepancreatitisandstonepassagerates
[1, 3–6].
An unexpected ﬁnding was the similar levels of bilirubin
found at admission in both the Decrescendo group and
the Crescendo-Decrescendo group of patients. Stratiﬁcation
of bilirubin into diﬀerent levels also showed no diﬀer-
ence between the 2 groups. Sixty percent of patients in
the Crescendo-Decrescendo group had bilirubin levels on
admission less than 5mg/dL and this observation supports
the ﬁnding of shorter duration of presenting symptoms in
this group. The prevalence of common bile duct dilation was
also similar in both groups. The patients in the Crescendo-
Decrescendo group however were signiﬁcantly older and
combinedwiththeirearlierpresentationwouldseemtoindi-
cate that the pain from gallstone migration or biliary tract
obstruction in these patients is less well tolerated than in the
younger patients. Studies have also shown that patients with
gallstonepancreatitisoftenhaverepeatedepisodeofgallstone
migration down the biliary tree and have a pathological
evidence of sclerosing papillitis [4]. We hypothesize that
olderpatientsmayhavemoreﬁbrosisoftheampullatogether
with decreased compliance of the common bile duct. This
possibly would lead to more frequent obstruction and earlier
onset of pain than in younger patients with less scarring
and ﬁbrosis, which would explain the ﬁndings in the study.
Anotherexplanationmightbethatinolderpopulationmight
have larger stones migrating through their ductal system.
Similarly we hypothesize that endoscopic manipulation
of the ampulla with or without sphincterotomy leads to
inﬂammation and swelling of the ampulla which would
explain why normalization of serum bilirubin was signiﬁ-
cantly delayed in our patient undergoing ERCP. Normaliza-
tion of bilirubin levels following spontaneous disobstruction
was signiﬁcantly faster than normalization that occurred
after ERCP. The rate of normalization was the same for
both Decrescendo and Crescendo-Decrescendo groups of
patients.
An interesting observation from this study, which diﬀers
signiﬁcantly from most other large series of patients with
gallstone pancreatitis, was that the median age of the
patients in this study was only 35 years. This is almost
half the value reported by other series [8, 17–19]. Our
population seems unique in consisting of a large number
of young Hispanic patients and very few Medicare aged
patients.Thisobservationshouldbetakenintoaccountwhen
comparing the result of this study to others. We have shown
that the younger patients have a very rapid resolution of
biochemical evidence of obstruction most probably related
to the elasticity, increased compliance and functionality of
the biliary tract that has not been subjected to repeated
episodes of destructive inﬂammation or passage of gallstones
that would be expected in older patient populations.
Because of the high incidence of gallstones disease and
gallstone pancreatitis our institution, we have adopted an
aggressive approach to monitor the trend of biochemical
markers with laboratory testing every 6 hours in an eﬀort to
guide the judicious use of ERCP. We have shown previously
that early stratiﬁcation of patients based on the likelihood
of passage of stones may improve overall morbidity [15].
Those with a unremitting Crescendo pattern should perhaps
considered for magnetic resonance cholangiopancreatog-
raphy (MRCP) [20, 21] or ERCP. Those patients with a
Decrescendo trend do not need any imaging of the CBD
and can be scheduled for surgery once the pancreatitis has
settled.
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